AMLX
Amylyx Pharmaceuticals Inc
30.60$
-7.3%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 93.0% | 89.8% | 98.3% | 98.4% | 97.8% | 97.8% | 98.4% | 96.0% | 97.4% | 97.3% | 97.1% | 96.9% | |
| 29.0% | 32.9% | 40.9% | 22.6% | 28.7% | 40.0% | 27.2% | 29.8% | 62.1% | 68.1% | 78.0% | 18.6% | |
| 76.1% | 71.8% | 89.4% | 93.3% | 93.5% | 91.2% | 92.9% | 92.9% | 94.8% | 95.3% | 95.3% | 94.8% | |
| 6.3% | 7.7% | 4.9% | 1.2% | 0.7% | 0.2% | 0.1% | 0.1% | 0.1% | 0.0% | 0.0% | – | |
| 6.9% | 7.4% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | |
| 10.3% | 16.2% | 22.3% | 21.3% | 21.7% | 14.9% | 8.3% | 13.7% | 8.5% | 8.2% | 7.0% | 9.6% | |
| 9.8% | 15.9% | 22.0% | 21.1% | 21.5% | 14.7% | 8.2% | 11.0% | 7.1% | 6.8% | 5.4% | 8.0% | |
| 0.5% | 0.4% | 0.6% | 0.7% | 0.8% | 0.8% | 0.5% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | |
| 1.4% | 4.3% | 5.1% | 1.5% | 0.6% | 1.5% | 2.2% | 1.7% | 1.5% | 1.1% | 1.2% | 2.1% | |
| 89.7% | 83.8% | 77.7% | 78.7% | 78.3% | 85.1% | 91.7% | 86.3% | 91.5% | 91.8% | 93.0% | 90.4% | |
| -66.4% | -58.9% | -101.5% | -149.5% | -227.0% | -313.3% | -292.5% | -351.5% | -198.1% | -225.9% | -270.0% | -316.0% | |
| 14.9% | 13.4% | 16.3% | 20.5% | 27.2% | 35.4% | 39.0% | 45.8% | 25.7% | 28.4% | 37.7% | 42.0% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.